Skip to main content
. 2019 Jul 23;10(45):4664–4678. doi: 10.18632/oncotarget.27083

Table 2. MiR-190b hypomethylation status according to BRCA2 mutation status in ER+ tumors.

MiR-190b non hypomethylation (%) MiR-190b hypomethylation (< 20%)
BRCA2999del5 carriers 26 (81.3%) 6 (18.7%)
WT 173 (62.7%) 103 (37.3%)
P = 0.038, Χ2 = 4.32